June 30, 2026
GRIN Therapeutics’ Pivotal Phase 3 Beeline Study Initiated in Europe
B European initiation advances global registrational program for investigational radiprodil in GRIN-NDD; initiation augments sites already enrolling in the US and UK NEW YORK, May…
